Elevance Health, Inc. Quarterly Interest Expense in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Elevance Health, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q3 2024.
  • Elevance Health, Inc. Interest Expense for the quarter ending September 30, 2024 was $300M, a 15.8% increase year-over-year.
  • Elevance Health, Inc. Interest Expense for the twelve months ending September 30, 2024 was $1.1B, a 10.4% increase year-over-year.
  • Elevance Health, Inc. annual Interest Expense for 2023 was $1.03B, a 21% increase from 2022.
  • Elevance Health, Inc. annual Interest Expense for 2022 was $851M, a 6.64% increase from 2021.
  • Elevance Health, Inc. annual Interest Expense for 2021 was $798M, a 1.79% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.1B $300M +$41M +15.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-17
Q2 2024 $1.06B $280M +$19M +7.28% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-17
Q1 2024 $1.04B $265M +$14M +5.58% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-18
Q4 2023 $1.03B $259M +$30M +13.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $1B $259M +$46M +21.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-17
Q2 2023 $954M $261M +$53M +25.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-17
Q1 2023 $901M $251M +$50M +24.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-18
Q4 2022 $851M $229M +$29M +14.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $822M $213M +$12M +5.97% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 $810M $208M +$3M +1.46% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-09-29
Q1 2022 $807M $201M +$9M +4.69% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-19
Q4 2021 $798M $200M +$9M +4.71% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $789M $201M +$3M +1.52% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-19
Q2 2021 $786M $205M +$4M +1.99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $782M $192M -$2M -1.03% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-20
Q4 2020 $784M $191M +$1M +0.53% Oct 1, 2020 Dec 31, 2020 10-Q 2023-10-18
Q3 2020 $783M $198M +$13M +7.03% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $770M $201M +$17M +9.24% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-21
Q1 2020 $753M $194M +$7M +3.74% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-21
Q4 2019 $746M $190M +$1M +0.53% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $745M $185M -$3M -1.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 $748M $184M -$8M -4.17% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $756M $187M +$3M +1.63% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $753M $189M +$24.9M +15.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-18
Q3 2018 $728M $188M +$38M +25.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-23
Q2 2018 $690M $192M +$2.1M +1.11% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $688M $184M -$51M -21.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $739M $164M -$13.2M -7.45% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-19
Q3 2017 $752M $150M -$22.9M -13.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $775M $190M +$4.2M +2.26% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-25
Q1 2017 $771M $235M +$47.9M +25.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $723M $177M -$2.4M -1.34% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-20
Q3 2016 $725M $173M +$8.1M +4.92% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 $717M $186M +$31.6M +20.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $686M $187M +$32.7M +21.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $653M $180M +$26.1M +17% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $627M $165M +$9.5M +6.12% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $617M $154M +$8.5M +5.84% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-27
Q1 2015 $609M $154M +$8.2M +5.61% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q4 2014 $601M $154M +$7.8M +5.35% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 $593M $155M +$3.8M +2.51% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-28
Q2 2014 $589M $146M -$6.3M -4.15% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 $595M $146M -$7.3M -4.76% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $603M $146M -$5.7M -3.76% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $608M $152M +$17.9M +13.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $591M $152M +$34.3M +29.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-30
Q1 2013 $556M $154M +$44.4M +40.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $512M $152M +$38.9M +34.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $473M $134M +$25.4M +23.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-23
Q2 2012 $448M $118M +$14M +13.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-24
Q1 2012 $434M $109M +$3.2M +3.02% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-24
Q4 2011 $430M $113M -$400K -0.35% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-20
Q3 2011 $431M $108M +$1.9M +1.79% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $429M $104M +$3.4M +3.39% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 $425M $106M +$6.5M +6.54% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-25
Q4 2010 $419M $113M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-22
Q3 2010 $106M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-26
Q2 2010 $100M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-27
Q1 2010 $99.4M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.